{
  "meta": {
    "title": "Thyroid",
    "url": "https://brainandscalpel.vercel.app/thyroid-57464a9c.html",
    "scrapedAt": "2025-11-29T18:33:55.264Z"
  },
  "questions": [
    {
      "id": 3751,
      "choices": [
        {
          "id": 14983,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Liraglutide</span></span></span></p>"
        },
        {
          "id": 14984,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Sitagliptin</span></span></span></p>"
        },
        {
          "id": 14985,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Canagliflozin</span></span></span></p>"
        },
        {
          "id": 14986,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Pioglitazone</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">An obese diabetic patient was on metformin monotherapy, but his sugar levels were not well controlled. He is allergic to sulfa drugs and does not comply with injectable drugs. He has a history of pancreatitis, and family history of bladder carcinoma. In view of the raised glucose levels, you wish to add another anti-diabetic drug. Which one would you prefer? </span></span></span></p>",
      "unique_key": "Q7413394",
      "question_audio": null,
      "question_video": null,
      "map_id": 36103,
      "difficulty_level": "intermediate",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C. Canagliflozin</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In this clinical scenario, the <strong>choice of an additional anti-diabetic drug </strong>must consider the patient&rsquo;s <strong>specific health background </strong>and preferences. <strong>Canagliflozin</strong>, a <strong>sodium-glucose cotransporter 2 (SGLT2) inhibitor,</strong> is the most appropriate option. This class of medication<strong> lowers blood sugar </strong>by causing the <strong>kidneys to remove sugar from the body</strong> through the <strong>urine.</strong> It is suitable because it <strong>does not</strong> involve <strong>injection and does</strong> <strong>not </strong>have a known association with<strong> increased risk of pancreatitis or bladder carcinoma.</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Liraglutide:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Not </strong>suitable as it is an<strong> injectable GLP-1 receptor agonist,</strong> and the patient has a<strong> non-compliance issue</strong> with injectable medications.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Sitagliptin:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> A <strong>DPP-4 inhibitor,</strong> which has been associated with <strong>cases of pancreatitis</strong>, making it a <strong>less suitable </strong>option for a patient with a history of this condition.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Pioglitazone:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> A <strong>thiazolidinedione</strong> that has been associated with an i<strong>ncreased risk of bladder cancer</strong>, especially in individuals with a<strong> family history of the disease</strong>, thus <strong>contraindicating its use in this patient.</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><strong><u><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective: </span></span></u></strong></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/02/picture10.jpg\" style=\"height:415px; width:1000px\" /><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/02/picture11.jpg\" style=\"height:519px; width:1000px\" /></p>",
      "correct_choice_id": 14985,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 3651,
      "choices": [
        {
          "id": 14583,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">30% Amorphous + 70% Crystalline insulin</span></span></span></p>"
        },
        {
          "id": 14584,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">30% Crystalline + 70% Amorphous insulin</span></span></span></p>"
        },
        {
          "id": 14585,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Same as NPH insulin</span></span></span></p>"
        },
        {
          "id": 14586,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Only 70% amorphous insulin</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Lente insulin is composed of.</span></span></span></p>",
      "unique_key": "Q3278399",
      "question_audio": null,
      "question_video": null,
      "map_id": 36101,
      "difficulty_level": "intermediate",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A. 30% Amorphous &plusmn;70% Crystalline insulin</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Lente insulin</strong>, also known as<strong> Insulin Zinc Suspension</strong>, is a type of <strong>intermediate-acting insulin</strong> used to manage <strong>blood sugar levels</strong> in people with <strong>diabetes. </strong>It is composed of a<strong> mixture of 30% amorphous (or non-crystalline) and 70% crystalline insulin</strong>. This specific composition allows for a <strong>delayed absorption of insulin</strong>, providing a <strong>longer duration of action </strong>compared to short-acting insulin formulations. The <strong>crystalline portion dissolves slowly</strong>, ensuring a<strong> sustained release of insulin </strong>into the bloodstream, which helps in maintaining <strong>blood glucose levels </strong>more <strong>evenly over the day</strong>.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">30% Crystalline + 70% Amorphous insulin</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: This option <strong>inversely describes </strong>the composition of<strong> Lente insulin</strong>. The correct composition for Lente insulin is <strong>30% amorphous and 70% crystalline, </strong>not the other way around.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Same as NPH insulin</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: <strong>NPH (Neutral Protamine Hagedorn) </strong>insulin is another type of <strong>intermediate-acting insulin</strong>, but its composition <strong>differs from </strong>that of <strong>Lente insulin</strong>. NPH insulin is formulated by<strong> combining insulin with protamine </strong>to <strong>delay its action</strong>, not by varying the proportions of amorphous and crystalline insulin.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Only 70% amorphous insulin</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: This option <strong>does not </strong>accurately describe any <strong>standard insulin formulation. </strong>Lente insulin specifically contains both amorphous and crystalline insulin in the proportions of 30% and 70%, respectively.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Lente insulin&#39;s </strong>unique composition of <strong>30% amorphous and 70% crystalline insulin </strong>ensures a<strong> delayed absorption</strong>, providing an <strong>intermediate duration of action </strong>that is crucial for maintaining <strong>stable blood glucose levels </strong>in <strong>diabetes management</strong>.</span></span></span></p>",
      "correct_choice_id": 14583,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 3683,
      "choices": [
        {
          "id": 14711,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Advanced age</span></span></span></p>"
        },
        {
          "id": 14712,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Smoking</span></span></span></p>"
        },
        {
          "id": 14713,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Liver dysfunction</span></span></span></p>"
        },
        {
          "id": 14714,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Renal failure</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Metformin causes a severe, sometimes life-threatening side effect of lactic acidosis. All the following factors increase the risk of lactic acidosis except.</span></span></span></p>",
      "unique_key": "Q1062940",
      "question_audio": null,
      "question_video": null,
      "map_id": 36100,
      "difficulty_level": "intermediate",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B. Smoking </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Metformin </strong>is a<strong> biguanide </strong>class of <strong>antidiabetic medication </strong>primarily used for the management of<strong> Type 2 diabetes mellitus. </strong>It works by<strong> decreasing hepatic glucose production </strong>and <strong>improving insulin sensitivity</strong>. It can<strong> increase risk of lactic acidosis </strong>particularly in patients with<strong> liver disease, renal disease </strong>and those <strong>pre-disposed to hypoxia</strong>.</span><em><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Renal function </strong>usually <strong>reduces in elderly patients, </strong>so it is <strong>avoided in elderly also</strong>.</span></em></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Advanced age:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong> Increases the risk </strong>because <strong>renal function </strong>typically <strong>declines with age</strong>, affecting <strong>metformin&rsquo;s clearance and increasing </strong>the likelihood of<strong> adverse effects </strong>including <strong>lactic acidosis.</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Liver dysfunction:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> A significant<strong> risk factor as liver disease </strong>can<strong> impair lactate clearance </strong>leading to <strong>higher lactate levels </strong>in the body.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Renal failure:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Directly linked to an<strong> increased risk </strong>due to the role of the <strong>kidneys in clearing metformin from the body</strong>; <strong>reduced renal function </strong>can lead to <strong>accumulation of the drug </strong>and an <strong>increased risk of lactic acidosis</strong>.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><em><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Risk factors </strong>for <strong>metformin induced lactic acidosis</strong></span></em><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">:</span></span></span><br />\r\n&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cardiorespiratory insufficiency leading to hypoxia (as in hypotensive state, cardiovascular disease, severe anemia) etc. </span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hepatic failure </span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Renal failure </span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Alcoholics </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Elderly</span></span></span></span></span></span></span></span></span></li>\r\n</ul>",
      "correct_choice_id": 14712,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 3747,
      "choices": [
        {
          "id": 14967,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 24-year-old woman with type 1 diabetes with two positive spot microalbuminuria tests 1 week apart</span></span></span></p>"
        },
        {
          "id": 14968,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 32-year-old woman with type 1 diabetes with a blood glucose of 328 mg/dL and a positive spot microalbuminuria test</span></span></span></p>"
        },
        {
          "id": 14969,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 48-year-old man with type 2 diabetes with a positive spot microalbuminuria test 1 week after starting a new exercise program</span></span></span></p>"
        },
        {
          "id": 14970,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 56-year-old man with type 2 diabetes with two positive spot microalbuminuria tests 3 months apart&nbsp;</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following patients should be treated with either an angiotensin-converting enzyme (ACE) inhibitor or angiotensin receptor blocker?</span></span></span></p>",
      "unique_key": "Q6591996",
      "question_audio": null,
      "question_video": null,
      "map_id": 36102,
      "difficulty_level": "intermediate",
      "subjects_id": [
        4
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D) A 56-year-old man with type 2 diabetes with two positive spot microalbuminuria tests 3 months apart</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">The<strong> use of ACE inhibitors or ARBs</strong> is indicated in patients with diabetes who exhibit <strong>persistent microalbuminuria, </strong>as this is a marker of <strong>early diabetic nephropathy. </strong>It is<strong> essential to confirm persistent microalbuminuria </strong>with at<strong> least two positive tests</strong> <strong>spaced 3 to 6</strong> months apart, in the absence of other conditions that might<strong> cause transient increases in albumin excretion.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A.</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"> The testing <strong>interval of 1 week</strong> is too soon for confirmation of <strong>persistent microalbuminuria. </strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B.</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"> The presence of<strong> severe hyperglycemia </strong>can <strong>transiently increase albumin excretion</strong>, potentially confounding the <strong>test result. </strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C.</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong> Vigorous exercise </strong>can also transiently <strong>increase albumin excretion,</strong> making the test result unreliable.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong><u> </u></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">In the management of<strong> diabetic nephropathy, ACE inhibitors or ARBs </strong>should be initiated in patients with <strong>type 2 diabetes</strong> who have <strong>confirmed persistent microalbuminuria, </strong>indicated by <strong>at least two positive microalbuminuria tests </strong>spaced<strong> 3 to 6 months </strong>apart, <strong>without </strong>the influence of <strong>confounding factors.</strong></span></span></span></p>",
      "correct_choice_id": 14970,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 3676,
      "choices": [
        {
          "id": 14683,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Onapristone</span></span></span></p>"
        },
        {
          "id": 14684,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Gestrinone</span></span></span></p>"
        },
        {
          "id": 14685,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Mifepristone</span></span></span></p>"
        },
        {
          "id": 14686,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ulipristal</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following drug is a selective progesterone receptor modulator that can be used as an emergency contraceptive even after 3 days of unprotected intercourse?</span></span></span></p>",
      "unique_key": "Q1504037",
      "question_audio": null,
      "question_video": null,
      "map_id": 36105,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D. Ulipristal</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>All the drugs </strong>given in the options are <strong>selective progesterone receptor modulators. Mifepristone and ulipristal </strong>are recommended for <strong>emergency contraception</strong>.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Ulipristal and mifepristone </strong>can be used as <strong>emergency contraceptives</strong>.<strong> Mifepristone </strong>is effective if used <strong>within 72 hours </strong>of <strong>unprotected intercourse </strong>whereas<strong> ulipristal </strong>retains <strong>its efficacy </strong>till <strong>5 days of unprotected intercourse.</strong></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Ulipristal </strong>is a recently approved &lsquo;<strong>selective progesterone receptor modulator&rsquo; (SPRM) </strong>for use as <strong>emergency contraceptive</strong>. It inhibits<strong> ovulation (by suppressing LH surge). </strong>In addition, its action on <strong>endometrium </strong>can <strong>interfere </strong>with <strong>implantation</strong>. The efficacy of <strong>ulipristal (30 mg) as emergency contraceptive </strong>is equal to that of <strong>levonorgestrel (1.5 mg) </strong>when taken within<strong> 72 hours of unprotected intercourse</strong>. It is <strong>effective up to 5 days </strong>of unprotected intercourse unlike other emergency contraceptives.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Onapristone:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Although a <strong>selective progesterone receptor modulator</strong>, it is<strong> not </strong>indicated for <strong>emergency contraception.</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Gestrinone:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This <strong>SPRM is not </strong>commonly used for<strong> emergency contraception.</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Mifepristone:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Also an <strong>SPRM </strong>used for<strong> emergency contraception </strong>but is <strong>effective </strong>if used <strong>within 72 hours of unprotected intercourse</strong>, which is a<strong> shorter window compared to ulipristal.</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p><br />\r\n<span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Ulipristal (30 mg) </strong>is effective as an <strong>emergency contraceptive up to 5 days </strong>after <strong>unprotected intercourse</strong>, making it a superior option for <strong>extending </strong>the<strong> window of opportunity for emergency contraception </strong>compared to other options like <strong>mifepristone and levonorgestrel.</strong></span></span></span></p>",
      "correct_choice_id": 14686,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 4252,
      "choices": [
        {
          "id": 16985,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Liothyronine</span></span></span></p>"
        },
        {
          "id": 16986,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Levothyroxine</span></span></span></p>"
        },
        {
          "id": 16987,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Carbimazole</span></span></span></p>"
        },
        {
          "id": 16988,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Sodium iodide</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 26-year-old pregnant lady was taking Antithyroid drug for Graves&rsquo; disease throughout the pregnancy. Following delivery infant was diagnosed to have &ldquo;Aplasia Cutis congenita.&rdquo; Most probable drug the female was taking during pregnancy was.</span></span></span></p>",
      "unique_key": "Q1188464",
      "question_audio": null,
      "question_video": null,
      "map_id": 36104,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C. Carbimazole</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Carbimazole,</strong> a<strong> thioamide antithyroid drug</strong>, has been associated with<strong> causing birth defects</strong> such as <strong>aplasia cutis congenita</strong> and <strong>choanal atresia</strong> when taken <strong>during pregnancy</strong>, particularly if<strong> administered </strong>during the<strong> first trimester.</strong> This drug <strong>inhibits </strong>the enzyme <strong>thyroid peroxidase,</strong> which is crucial for the <strong>synthesis of thyroid hormones</strong>. The<strong> inhibition </strong>of this enzyme can lead to <strong>decreased</strong> <strong>thyroid hormone production.</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Carbimazole and methimazole</strong> use in <strong>pregnancy </strong>is associated with <strong>development of aplasia cutis and choanal atresia </strong>in the newborn baby.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A.</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Liothyronine:</strong> A <strong>synthetic form</strong> of <strong>triiodothyronine (T3)</strong>, <strong>not</strong> linked to congenital defects like <strong>aplasia cutis. </strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B.</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Levothyroxine:</strong> A <strong>synthetic form</strong> of <strong>thyroxine (T4), </strong>also<strong> not </strong>linked to <strong>congenital defects in infants. </strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D.</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Sodium Iodide:</strong> Used to<strong> correct iodine deficiency,</strong> <strong>not </strong>associated with causing <strong>aplasia cutis congenita.</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Thioamides:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Drugs in this include <strong>propylthiouracil, carbimazole and methimazole.</strong></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">These act by<strong> inhibiting the enzyme thyroid peroxidase</strong>. Later helps in <strong>formation</strong> of <strong>thyroid hormones. </strong></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Most serious adverse effect of <strong>thioamides is agranulocytosis</strong></span><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">. </span></strong></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Most common adverse effect of these drugs is <strong>purpuric rash. </strong></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Cholestatic jaundice </strong>is common with <strong>methimazole. </strong></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Propylthiouracil</strong> causes<strong> hepatic dysfunction,</strong> especially in <strong>children &amp; pregnant women.</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Methimazole and carbimazole </strong>are rarely associated with <strong>aplasia cutis and choanal atresia</strong> if given in the<strong> first trimester</strong> <strong>of pregnancy. </strong></span></span><strong> </strong></span></span></span></span></li>\r\n</ul>",
      "correct_choice_id": 16987,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    }
  ]
}